SCHEMBL7667994

SCHEMBL7667994

O=C(/C=C/c1ccccc1)OCO

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.69
AKR1B10 O60218 5/20 0.65
AKR1B1 P15121 5/20 0.65
CA12 O43570 1/20 0.58
CA4 P22748 1/20 0.58
CA6 P23280 1/20 0.58
CA5A P35218 1/20 0.58
CA7 P43166 1/20 0.58
CA9 Q16790 1/20 0.58
CA14 Q9ULX7 1/20 0.58
CA5B Q9Y2D0 1/20 0.58
ALDH1A1 P00352 2/20 0.55
HDAC3 O15379 1/20 0.55
TNKS O95271 1/20 0.55
HDAC4 P56524 1/20 0.55
HDAC1 Q13547 1/20 0.55
HCAR2 Q8TDS4 1/20 0.55
HDAC7 Q8WUI4 1/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC10 Q969S8 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27901596 1.00 LMNA (0.69) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL25361407 0.87 LMNA (0.54) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL25361411 0.87 LMNA (0.54) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL16234738 0.86 AKR1B10 (0.83) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL19279512 0.86 AKR1B10 (0.83) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL9855968 0.86 LMNA (0.71) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL9277968 0.86 AKR1B10 (0.83) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL9855964 0.86 LMNA (0.71) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL824875 0.85 AKR1B10 (0.71) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL2698661 0.85 AKR1B10 (0.71) LMNAAKR1B10AKR1B1CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122095297-A Composition for forming cured film, alignment material, and phase difference material 2026-05-26 CN disclosed
CN-111683986-B Composition for forming cured film, alignment material, and retardation material 日产化学株式会社 2025-01-10 CN disclosed
CN-119053661-A Composition for forming cured film, alignment material, and retardation material 日产化学株式会社 2024-11-29 CN disclosed
CN-119053888-A Resin composition for thermosetting photo-alignment film 日产化学株式会社 2024-11-29 CN disclosed
CN-113874470-B Composition for forming cured film, alignment member, and phase difference member 日产化学株式会社 2024-11-19 CN disclosed
CN-118715462-A Resin composition for thermosetting photo-alignment film 日产化学株式会社 2024-09-27 CN disclosed
CN-114746512-B Composition for forming cured film, alignment material, and retardation material 日产化学株式会社 2023-09-22 CN disclosed
CN-112384834-B Cured film, alignment material, and retardation material 日产化学株式会社 2023-08-11 CN disclosed
CN-115975155-A Composition for forming cured film for alignment material, and retardation material 日产化学株式会社 2023-04-18 CN disclosed
CN-114746512-A Composition for forming cured film, alignment material, and phase difference material 日产化学株式会社 2022-07-12 CN disclosed
EP-0879233-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-25 EP disclosed
US-5750699-A HALOGENATING OF CORRESPONDING COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
US-5708173-A PREPARATION OF SUBSTITUTED QUINOLINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-13 US disclosed
WO-1997041104-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-11-06 WO disclosed
WO-1997028153-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-07 WO disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed
US-5574042-A ANTAGONIST FOR BRADYKININS AS ANTIALLERGENS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS, SHOCK OR PAIN FUJISAWA PHARMACEUTICAL CO., LTD (JP) 1996-11-12 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed
EP-0596406-A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-11 EP disclosed